Federal grants to Pop Biotechnologies Inc
Pop Biotechnologies Inc in Buffalo, New York received $6.7 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Allergy and Infectious Diseases Research, with $3.1 million. In fiscal 2025 it was awarded $2.1 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$6.7 million
- Awards7
- Awarded in FY 2025$2.1 million
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $299,991 |
| FY 2022 | 2 | $1.3 million |
| FY 2023 | 2 | $1.2 million |
| FY 2024 | 4 | $1.7 million |
| FY 2025 | 3 | $2.1 million |
Programs that fund Pop Biotechnologies Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $3.1 million |
| Cancer Treatment Research | 1 | $2.0 million |
| Aging Research | 2 | $1.3 million |
| Cancer Detection and Diagnosis Research | 1 | $249,873 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 7 | $6.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Interstitial chemophototherapy with light-activated nanoparticulate doxorubicin - summary our goal is to commercialize interstitial chemo-phototherapy (i-cpt) as a new therapeutic option for locally advanced liver cancers. Doxorubicin (DOX) can be actively loaded into long circulating, serum-stable, | Cancer Treatment Research | September 8, 2022 | $2.0 million |
| Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment - abstract influenza is the cause of considerable morbidity and mortality globally. Despite immunization being the most effective and economical prophylactic approach, vaccines | Allergy and Infectious Diseases Research | May 31, 2024 | $1.9 million |
| Mosaic display of multivalent tau and a-beta peptides on immunogenic SNAP liposomes - project summary alzheimer’s disease (AD) currently affects ~6.2 million americans, and this number is projected to increase to 14 million by 2060 unless novel treatments or interventions to prevent or delay the ons | Aging Research | September 18, 2025 | $833,334 |
| Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant candida species - project summary the goal of this proposal is to develop an anti-candida peptide vaccine that works alone or as an adjunct to antifungal drugs to reduce fungal burden and morbidity due to life | Allergy and Infectious Diseases Research | August 1, 2024 | $600,000 |
| Developing a thermostable SARS-COV-2 rbd-particle vaccine - project summary the coronavirus disease 2019 (COVID-19) global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is unprecedented in our lifetime and has caused major social, economic and human suffering. Globa | Allergy and Infectious Diseases Research | July 9, 2021 | $599,982 |
| Mosaic display of multivalent tau and a-beta peptides on immunogenic SNAP liposomes - project summary/abstract alzheimer’s disease (AD) currently affects ~6.2 million americans, and this number is projected to increase to 14 million by 2060 unless novel treatments or interventions to prevent or dela | Aging Research | September 14, 2023 | $496,569 |
| Clinical translation of interstitial chemophototherapy with light-activated nanoparticulate doxorubicin - summary pop bio’s goal is to commercialize interstitial chemo-phototherapy (i-cpt) as a new therapeutic option for locally advanced liver cancers. Doxorubicin (DOX) can be actively loaded into l | Cancer Detection and Diagnosis Research | March 27, 2024 | $249,873 |
Questions people ask
How much federal grant money does Pop Biotechnologies Inc get?
$6.7 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Pop Biotechnologies Inc the most?
The Department of Health and Human Services, with $6.7 million in 7 awards.
What is Pop Biotechnologies Inc's largest federal grant?
$2.0 million under Cancer Treatment Research, with its first action in the period on September 8, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Pop Biotechnologies Inc?
Its largest are Allergy and Infectious Diseases Research, Cancer Treatment Research and Aging Research.
Other grant recipients in Buffalo
- The Research Foundation for the State University of New York
- Niagara Frontier Transportation Authority
- Health Research, Inc.
- Buffalo Municipal Housing Auth
- City of Buffalo
- The Community Action Organization of Western New York, Inc.
- University at Buffalo
- The Research Foundation for the State University of New York
Largest federal grant recipients in New York · Federal grants in New York